BIOMAT Database Logo BIOMAT Database Logo

Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitors. 1993

M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
Department of Virology, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492-7660.

A novel substituted naphthalenone (TGG-II-23A) has been found that inhibits HIV-1 infection of CEM-SS cells at concentrations that are not cytotoxic. Time of addition experiments indicate that TGG-II-23A functions at a stage of the HIV-1 life cycle at or near reverse transcription. Cell free assays confirmed that TGG-II-23A inhibits HIV-1 reverse transcriptase. Similar to other non-nucleoside inhibitors, TGG-II-23A was specific for HIV-1 and failed to inhibit the replication of HIV-2. The binding site of TGG-II-23A appears to be in close proximity to that of the TIBO-like inhibitors, since a TIBO-resistant HIV-1 was also resistant to TGG-II-23A treatment. TGG-II-23A is a mixed non-competitive inhibitor that exhibits the same template:primer selectivity as other non-nucleoside inhibitors. TGG-II-23A therefore represents a new structural entry into the TIBO/Nevirapine class of inhibitors of HIV-1 reverse transcriptase.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
Truncated reverse isoxazolidinyl nucleosides: a new class of allosteric HIV-1 reverse transcriptase inhibitors.
April 2012, ChemMedChem,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
February 2019, ACS medicinal chemistry letters,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
Designing hypothesis of substituted benzoxazinones as HIV-1 reverse transcriptase inhibitors: QSAR approach.
October 2012, Journal of enzyme inhibition and medicinal chemistry,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
2-Pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors.
September 1991, Journal of medicinal chemistry,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors.
April 2014, Bioorganic & medicinal chemistry,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928).
May 2016, Expert opinion on therapeutic patents,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors.
July 2010, Journal of medicinal chemistry,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase.
September 2003, Current medicinal chemistry,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
HIV-1 reverse transcriptase inhibitors.
June 2007, Applied microbiology and biotechnology,
M Alam, and C M Bechtold, and A K Patick, and M T Skoog, and T G Gant, and R J Colonno, and A I Meyers, and H Li, and J Trimble, and P F Lin
New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
June 2009, Journal of medicinal chemistry,
Copied contents to your clipboard!